Register for tracking leptomeningeal disease in Germany
Deutsches Meningeosis Neoplastica Register
University Hospital Tuebingen · NCT06146010
This study is setting up a database to track how leptomeningeal disease affects patients in Germany, including their treatments and any complications, to better understand the condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital Tuebingen (other) |
| Locations | 7 sites (Bonn and 6 other locations) |
| Trial ID | NCT06146010 on ClinicalTrials.gov |
What this trial studies
This multicenter register aims to create a comprehensive database on the incidence and progression of leptomeningeal disease in Germany. It collects data on therapeutic measures and complications experienced by patients in real-world settings. Patients eligible for the register will provide informed consent, and their clinical data will be documented without any interventions or health risks involved. The register will utilize diagnostic findings and routine clinical practice letters from participating medical centers to gather information.
Who should consider this trial
Good fit: Ideal candidates for this register are adults aged 18 and older diagnosed with leptomeningeal disease who can provide informed consent.
Not a fit: Patients under 18 years old or those unable to provide informed consent will not benefit from this register.
Why it matters
Potential benefit: If successful, this register could enhance understanding of leptomeningeal disease and improve patient management strategies.
How similar studies have performed: While this register approach is observational and not novel, similar registries have successfully contributed to understanding disease patterns and treatment outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with leptomeningeal disease * Written consent of the patient or legal guardian. * Capacity to give consent or legal guardianship * Age ≥ 18 years Exclusion Criteria: * Lack of informed consent from the patient * Lack of capacity to consent on the part of the person concerned or lack of legal guardianship * Age \< 18 years
Where this trial is running
Bonn and 6 other locations
- Universitätsklinikum Bonn Klinik und Poliklinik für Neurologie — Bonn, Germany (RECRUITING)
- Universitätsmedizin Mannheim Universitätsklinikum Mannheim GmbH Klinik für Neurologie — Mannheim, Germany (RECRUITING)
- Klinikum rechts der Isar | Technische Universität München; Klinik für Radioonkologie und Strahlentherapie — München, Germany (RECRUITING)
- Überörtliche Gemeinschaftspraxis für Hämatologie und Onkologie — Münster, Germany (NOT_YET_RECRUITING)
- Diakonie Klinikum GmbH • Jung-Stilling-KrankenhausAbteilung Neurochirurgie — Siegen, Germany (RECRUITING)
- University Hospital Tübingen, Neurooncology — Tübingen, Germany (RECRUITING)
- Universitätsklinikum Ulm; Klinik für Innere Medizin III — Ulm, Germany (RECRUITING)
Study contacts
- Study coordinator: Ghazaleh Tabatabai, Prof
- Email: Tabatabai.Office@med.uni-tuebingen.de
- Phone: +497071-29
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Meningeal Neoplasms, Leptomeningeal Disease, Meningeosis Neoplastica